IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 133 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,000 | +13.7% | 42,020 | +77.0% | 0.00% | – |
| Q2 2023 | $168,000 | +147.1% | 23,740 | +112.2% | 0.00% | – |
| Q1 2023 | $68,000 | -54.7% | 11,190 | -52.5% | 0.00% | – |
| Q4 2022 | $150,000 | +212.5% | 23,580 | +365.5% | 0.00% | – |
| Q3 2022 | $48,000 | +33.3% | 5,066 | +54.5% | 0.00% | – |
| Q2 2022 | $36,000 | -66.4% | 3,279 | -49.2% | 0.00% | – |
| Q1 2022 | $107,000 | -18.9% | 6,454 | -6.7% | 0.00% | – |
| Q4 2021 | $132,000 | -32.3% | 6,915 | -13.0% | 0.00% | – |
| Q3 2021 | $195,000 | -78.1% | 7,949 | -76.8% | 0.00% | – |
| Q2 2021 | $892,000 | +1089.3% | 34,273 | +1357.2% | 0.00% | – |
| Q1 2021 | $75,000 | -73.8% | 2,352 | -61.9% | 0.00% | – |
| Q4 2020 | $286,000 | -95.1% | 6,177 | -96.5% | 0.00% | -100.0% |
| Q3 2020 | $5,825,000 | +36.6% | 176,967 | +13.9% | 0.00% | 0.0% |
| Q2 2020 | $4,265,000 | +33.0% | 155,431 | +45.2% | 0.00% | 0.0% |
| Q1 2020 | $3,206,000 | +245.1% | 107,073 | +219.1% | 0.00% | – |
| Q4 2019 | $929,000 | +144.5% | 33,559 | +60.6% | 0.00% | – |
| Q3 2019 | $380,000 | +874.4% | 20,895 | +1205.9% | 0.00% | – |
| Q2 2019 | $39,000 | +95.0% | 1,600 | -23.8% | 0.00% | – |
| Q1 2019 | $20,000 | +42.9% | 2,100 | +36.8% | 0.00% | – |
| Q4 2018 | $14,000 | -66.7% | 1,535 | -58.4% | 0.00% | – |
| Q3 2018 | $42,000 | +110.0% | 3,690 | +134.7% | 0.00% | – |
| Q2 2018 | $20,000 | -61.5% | 1,572 | -48.9% | 0.00% | – |
| Q1 2018 | $52,000 | +477.8% | 3,076 | +188.0% | 0.00% | – |
| Q4 2017 | $9,000 | -82.0% | 1,068 | -83.2% | 0.00% | – |
| Q3 2017 | $50,000 | +733.3% | 6,341 | +645.1% | 0.00% | – |
| Q2 2017 | $6,000 | – | 851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |